Dr Reddy’s has launched the second generic version of Amarin’s Vascepa (icosapent ethyl) 1g capsules in the US, putting it in direct competition with both the brand and Hikma’s first-to-market generic. The move comes immediately in the wake of the US Supreme Court denying the originator’s petition for certiorari review of a Federal Circuit decision that affirmed as invalid six patents shielding the purified fish oil brand.
The launch shakes up the generic icosapent ethyl market in the US, while also raising questions over supply of the...



